Oral Presentation
Chairs: R. Schermuly (Giessen, Germany), H. Bogaard (Amsterdam, Netherlands)

Bacterial translocation in pulmonary hypertension F. Perros (Le Kremlin Bicetre, France)
Contribution of BMP9 to Pulmonary Arterial Hypertension A. Sekine (Le Plessis-Robinson, France)
Regulation of the pulmonary vascular tone by p66shc and cyclophilin D M. Gierhardt (Buenos Aires, Argentina)
The effect of 6-mercaptopurine treatment on experimentally induced pulmonary arterial hypertension X. Sun (Amsterdam, Netherlands)
Bone marrow transplantation reduces susceptibility to pulmonary hypertension in BMPR2 deficient mice A. Crosby (Cambridge, United Kingdom)
Pharmacokinetics and pre-clinical efficacy of ralinepag (APD811) in humans and rats J. Adams (San Diego, United States of America)
Reversal of pulmonary hypertension in a sugen/hypoxic rat model using an ASK1 inhibitor K. Wilson (GLASGOW, United Kingdom)